Nearly six months after lodging a similar complaint against Pfizer and BioNTech over the partners’ COVID shot Comirnaty, GSK is targeting Moderna in a pair of lawsuits alleging the Massachusetts-ba | ...
British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of ...
GlaxoSmithKline has filed lawsuits against Moderna in a Delaware federal court, alleging infringement of patents related to ...
Pharmaceutical firm GlaxoSmithKline (GSK) announced Tuesday it received approval from the Food and Drug Administration (FDA) ...
GlaxoSmithKline has filed lawsuits against Moderna in the U.S., claiming infringement on its mRNA technology patents with ...
The chronic obstructive pulmonary disease (COPD) market in the seven major markets (7MM: US, France, Germany, Italy, Spain, ...
GlobalData on MSN20h
GSK’s depemokimab shows promise in Phase III trials for chronic rhinosinusitisBoth trials met their primary endpoints, indicating a significant improvement in patients treated with the drug.
Moderna Inc.’s shots for Covid-19 and respiratory syncytial virus infringe as many as seven GSK Plc patents related to mRNA ...
Bonus Aug 17, 1998 Sep 20, 1998 Aug 10, 1998 Bonus Ratio: 1 share(s) for every 1 shares held Rights--Feb 02, 1994 Rights ratio: 1 share for every 10 held at a price of Rs 15.0 Bonus--Jun 22, 1988 ...
Bonus Oct 05, 1998 Oct 30, 1998 Aug 29, 1998 Bonus Ratio: 1 share(s) for every 1 shares held Rights Jun 10, 1996-Dec 07, 1996 Rights ratio: 1 share for every 5 held at a price of Rs 80.0 Bonus Oct 01, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback